Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
S. Tjulandin, E. Imyanitov, V. Moiseyenko, D. Ponomarenko, L. Gurina, I. Koroleva & V. Karaseva. (2015) Prospective cohort study of clinical characteristics and management patterns for patients with non-small-cell lung cancer in the Russian Federation: EPICLIN-Lung. Current Medical Research and Opinion 31:6, pages 1117-1127.
Read now
Read now
Articles from other publishers (27)
Americo Cicchetti, Roberta Laurita & Luca Giorgio. (2023) L'importanza dell'organizzazione in oncologia: collaborazione e coordinamento. Evidenze da una ricerca intervento sul tumore del polmone. MECOSAN:124, pages 93-111.
Crossref
Crossref
Cliff Molife, Katherine B. Winfree, Hollie Bailey, Yulia D’yachkova, Cameron Forshaw, Sangmi Kim, Kaisa-Leena Taipale & Tarun Puri. (2023) Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study. Advances in Therapy 40:7, pages 3135-3168.
Crossref
Crossref
Bin Huang, Gongzhi Wu, Chongxiong Peng, Xuyang Peng, Mingjiang Huang, Jianyang Ding, Huaizhong Zhang & Xuhui Wu. (2021)
miR
‐126 regulates the proliferation, migration, invasion, and apoptosis of
non‐small
lung cancer cells via
AKT2
/
HK2
axis
. IUBMB Life 75:3, pages 186-195.
Crossref
Crossref
Chaonan Zhu, Shuai Wang, Maogen Zheng, Zhiquan Chen, Guochen Wang, Jun Ma, Bin Zhang, Wuhao Huang, Xiaoyan Sun & Changli Wang. (2022) miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis. Strahlentherapie und Onkologie 198:3, pages 304-314.
Crossref
Crossref
Tania Losanno & Cesare Gridelli. (2021) First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly. Current Oncology Reports 23:10.
Crossref
Crossref
Andrea Ricotti, Veronica Sciannameo, William Balzi, Andrea Roncadori, Paola Canavese, Arianna Avitabile, Ilaria Massa & Paola Berchialla. (2021) Incidence and Prevalence Analysis of Non-Small-Cell and Small-Cell Lung Cancer Using Administrative Data. International Journal of Environmental Research and Public Health 18:17, pages 9076.
Crossref
Crossref
M. Or, B. Liu, J. Lam, S. Vinod, W. Xuan, R. Yeghiaian-Alvandi & E. Hau. (2021) A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer. Scientific Reports 11:1.
Crossref
Crossref
Matthew Evison. (2020) The current treatment landscape in the UK for stage III NSCLC. British Journal of Cancer 123:S1, pages 3-9.
Crossref
Crossref
Xia Wang, Dongming Shi, Dejun Zhao & Danping Hu. (2020) Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma. BioMed Research International 2020, pages 1-8.
Crossref
Crossref
Yingqing Zhang, Xiaoping Zhang, Xiaodong Lv, Ming Zhang, Xixi Gao, Jialiang Liu, Yufen Xu, Zhixian Fang & Wenyu Chen. (2020) Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma. BioMed Research International 2020, pages 1-10.
Crossref
Crossref
Isabel Linares, José Expósito, Elena Molina-Portillo, Yoe-Ling Chang, Juan Pedro Arrebola, Julia SánchezCantalejo, Jaime Pérez-Alija, Miguel Rodríguez-Barranco, María Rosa Guerrero & María José Sánchez. (2019) Prognostic Factors Associated with Lung Cancer Survival: A Population-Based Study in Southern Spain. Clinical Oncology and Research, pages 1-10.
Crossref
Crossref
Maurice Pérol, Katherine B. Winfree, Gebra Cuyun Carter, Zhanglin Lin Cui, Lee Bowman & Edward B. Garon. (2019) Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer. Lung Cancer 131, pages 6-13.
Crossref
Crossref
Andrew D. Nguyen, Wenchang Wong, Nadine Beydoun, Sharanya Mohan, Jesmin Shafiq & Shalini K. Vinod. (2018)
Radiotherapy patterns of care for stage I and
II
non‐small cell lung cancer in Sydney, Australia
. Journal of Medical Imaging and Radiation Oncology 63:1, pages 131-141.
Crossref
Crossref
Nicola Amedeo Mazzanti, Carolina Scauri, Bianca Domini, Chiara Vassallo, Simone Cusato, Chiara De Fino & Filippo de Marinis. (2019) Advanced-Metastatic Non-Small-Cell Lung Cancer EGFR-mutated in Italy: patient management costs and potential productivity losses. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2019, pages 228424031987789.
Crossref
Crossref
Yanling Xu, Zhenzhong Su, Junyao Li, Qi Wang, Guangping Meng, Yu Zhang, Wen Yang, Jie Zhang & Peng Gao. (2018) Role of RNA‑binding protein 5 in the diagnosis and chemotherapeutic response of lung cancer (Review). Oncology Letters.
Crossref
Crossref
David Campbell, Ken O’Day, Nadine Hertel, John R. Penrod, Melinda Manley Daumont & Michael Lees. (2018) The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions. Population Health Metrics 16:1.
Crossref
Crossref
Wolfgang Schuette, Peter Schirmacher, Wilfried E. E. Eberhardt, Manfred Dietel, Ute Zirrgiebel, Lars Muehlenhoff & Michael Thomas. (2018) Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study. BMC Cancer 18:1.
Crossref
Crossref
Dae Ho Lee, Ming-Sound Tsao, Karl-Otto Kambartel, Hiroshi Isobe, Ming-Shyan Huang, Carlos H. Barrios, Adnan Khattak, Filippo de Marinis, Smita Kothari, Ashwini Arunachalam, Xiting Cao, Thomas Burke, Amparo Valladares & Javier de Castro. (2018) Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study. PLOS ONE 13:8, pages e0202865.
Crossref
Crossref
J. de Castro, P. Tagliaferri, V.C.C. de Lima, S. Ng, M. Thomas, A. Arunachalam, X. Cao, S. Kothari, T. Burke, H. Myeong, A. Grattan & D.H. Lee. (2017) Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study. European Journal of Cancer Care 26:6, pages e12734.
Crossref
Crossref
Yi-ju Cheng, Ran Wu, Ming-liang Cheng, Juan Du, Xi-wei Hu, Lei Yu, Xue-ke Zhao, Yu-mei Yao, Qi-zhong Long, Li-li Zhu, Juan-juan Zhu, Ni-wen Huang, Hua-juan Liu, Ya-xin Hu & Fang Wan. (2016) Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions. Oncotarget 8:19, pages 32228-32236.
Crossref
Crossref
Nicolas Girard, Jesus Corral, Diego Cortinovis & David F. Heigener. (2017) Second-Line Treatment Selection in Patients With Non–Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians. Clinical Lung Cancer 18:2, pages e89-e97.
Crossref
Crossref
Clare E. Weeden, Yunshun Chen, Stephen B. Ma, Yifang Hu, Georg Ramm, Kate D. Sutherland, Gordon K. Smyth & Marie-Liesse Asselin-Labat. (2017) Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway. PLOS Biology 15:1, pages e2000731.
Crossref
Crossref
Maurice Pérol, Tudor-Eliade Ciuleanu, Oscar Arrieta, Kumar Prabhash, Konstantinos N. Syrigos, Tuncay Goksel, Keunchil Park, Ruben Dario Kowalyszyn, Joanna Pikiel, Conrad R. Lewanski, Michael Thomas, Shaker Dakhil, Joo-Hang Kim, Nina Karaseva, Sergey Yurasov, Annamaria Zimmermann, Pablo Lee, Gebra Cuyun Carter, Martin Reck, Federico Cappuzzo & Edward B. Garon. (2016) Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy. Lung Cancer 93, pages 95-103.
Crossref
Crossref
Liza C. Villaruz & Mark A. Socinski. (2016) Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes. European Journal of Cancer 56, pages 162-171.
Crossref
Crossref
Denis Moro-Sibilot, Egbert Smit, Javier de Castro Carpeño, Krzysztof Lesniewski-Kmak, Joachim Aerts, Rosa Villatoro, Kees Kraaij, Karim Nacerddine, Yulia Dyachkova, Karen T. Smith, Kaisa Taipale, Allicia C. Girvan, Carla Visseren-Grul & Philipp A. Schnabel. (2015) Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. Lung Cancer 88:2, pages 215-222.
Crossref
Crossref
Shalini K. Vinod. (2015) International Patterns of Radiotherapy Practice for Non–Small Cell Lung Cancer. Seminars in Radiation Oncology 25:2, pages 143-150.
Crossref
Crossref
S.K. Vinod. (2015) Decision Making in Lung Cancer – How Applicable are the Guidelines?. Clinical Oncology 27:2, pages 125-131.
Crossref
Crossref